Femasys Inc. (FEMY)
Oxford Ledge is still expanding full research coverage of FEMY. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
A U.S. biomedical company develops in-office diagnostic and therapeutic devices for women's infertility, birth control, and cervical cancer screening, with multiple products approved globally.
SEC filings
- 8-K Shareholder vote results 2026-06-24
- 8-K Other material event; Financial statements and exhibits 2026-06-24
- 8-K 3.03; Amendments to articles or bylaws; Financial statements and exhibits 2026-06-05
- 8-K Regulation FD disclosure 2026-06-04
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-05-13
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for FEMY. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open FEMY in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.